Vimarsana
Biggest News Aggregation in the World

Page 29 - Pharma Research News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Pharma Research. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Pharma Research Today - Breaking & Trending Today

Relief Therapeutics Files Amendment No. 4 to its Registration Statement on Form 20-F with the U.S. Securities and Exchange Commission - Vimarsana News

Relief Therapeutics Files Amendment No. 4 to its Registration Statement on Form 20-F with the U.S. Securities and Exchange Commission

Relief Therapeutics Holding SA / Key word(s): Miscellaneous Relief Therapeutics Files Amendment No. 4 to its Registration Statement on Form 20...

Adhoc: Relief Therapeutics Holding SA: Relief Therapeutics Reports that its U.S. Collaboration Partner has Announced that the FDA has Declined Emergency Use Authorization for Aviptadil for a Subgroup of Patients with Critical COVID-19 at Immediate Risk - Vimarsana News

Adhoc: Relief Therapeutics Holding SA: Relief Therapeutics Reports that its U.S. Collaboration Partner has Announced that the FDA has Declined Emergency Use Authorization for Aviptadil for a Subgroup of Patients with Critical COVID-19 at Immediate Risk

Relief Therapeutics Holding SA / Key word(s): Regulatory Approval Relief Reports that its U.S. Collaboration Partner has Announced that the FDA has Declined Emergency Use Authorization for Aviptadil

Buyer sought for life sciences firm 4D Pharma after it enters administration - Vimarsana News

Buyer sought for life sciences firm 4D Pharma after it enters administration

Administrators are seeking a buyer for pharmaceutical company 4D Pharma. Aberdeen-based 4D Research continues to trade.

Life sciences firm 4D Pharma in administration - Vimarsana News

Life sciences firm 4D Pharma in administration

Drug company 4D Pharma is in administration after its lender suddenly pulled the plug on its support and demanded its money back.

Adhoc: Relief Therapeutics Holding SA: Acer Therapeutics and Relief Therapeutics Announce Update on U.S. FDA Review of New Drug Application (NDA) for ACER-001 - Vimarsana News

Adhoc: Relief Therapeutics Holding SA: Acer Therapeutics and Relief Therapeutics Announce Update on U.S. FDA Review of New Drug Application (NDA) for ACER-001

Relief Therapeutics Holding SA / Key word(s): Regulatory Approval Acer Therapeutics and Relief Therapeutics Announce Update on U.S. FDA Review of New Drug Application (NDA) for ACER-001 21-Jun-2022